跳至主要内容
临床试验/NCT02944331
NCT02944331Unknown不适用

3-4 Year Outcomes Following Endovenous Steam Ablation of the Saphenous Veins for the Treatment of Venous Insufficiency

Lovisenberg Diakonale Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
200
试验地点
1
主要终点
Vein obliteration or abolition of reflux

研究概览

简要总结

The aim of this study is to evaluate the long-term effects of endovenous steam ablation (EVSA). Postoperative data at 3-4 year follow-up will be collected from patients treated with EVSA.

详细描述

Endovenous steam ablation (EVSA) of saphenous veins (saphenous vein reflux) is one of the endothermal methods in the modern treatment of venous insufficiency. Good results and long-term follow-up have been published for endovenous laser ablation (EVLA) and radiofrequency ablation (RFA), while long-term effects of EVSA are less documented. Therefore, the aim of this study is to evaluate the effect of EVSA in 200 consecutive patients treated with EVSA and conduct prospective evaluations at 3-4 year follow-up. Standardized and validated measures will be compared to preoperative measures to evaluate change in patient-reported and clinical outcomes over time.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Received steam ablation for treatment of saphenous vein reflux (clinical classes C2-C4) at Lovisenberg Diakonale Hospital 3-4 years (i.e, 36-48 months) prior to study enrollment.
  • •Ability to speak, understand, read, and write Norwegian in order to complete follow-up exams and questionnaires.

排除标准

  • •<18 years of age

结局指标

主要结局

Vein obliteration or abolition of reflux

时间窗: 3-4 years after treatment

As determined by duplex scanning

次要结局

  • Recanalization(3-4 years after treatment)
  • Venous Clinical Severity Score(3-4 years after treatment)
  • Aberdeen Varicose Vein Questionnaire(3-4 years after treatment)
  • Recurrent varicosities(3-4 years after treatment)

研究者

发起方
Lovisenberg Diakonale Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验